Sozinibercept
Product Specifications
CAS Number
2568358-31-4
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Sozinibercept (OPT 302; VGX-300) is a soluble form of Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) that potently inhibits the activity of Vascular Endothelial Growth Factor-C and -D (VEGF-C/D), key proangiogenic factors involved in promoting angiogenesis and vascular leakage. Additionally, Sozinibercept has been shown to inhibit diabetic retinal edema in rats [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP312858L 1 mg
Parathyroid hormone related protein (PTHLH) (NM_002820) Human Recombinant Protein
Sign In for Pricing
View Details 
A01183-1-FITC 100 µg/Vial
Anti-PHO1/APOBEC3A Antibody Picoband® (FITC Conjugate)
Sign In for Pricing
View Details 168892-AF-ML650 100 µL
Von Willebrand Factor (Factor VIII Related-Ag, Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD) ) (BSA & Azide Free) (MaxLight 650)
Sign In for Pricing
View Details MBS6243849-01 0.1 mL
Integrin, beta1, active (ITGB1, Integrin, beta 1 (Fibronectin Receptor, beta Polypeptide, Antigen CD29 includes MDF2, MSK12), CD29, Fibronectin Receptor Subunit beta, FNRB, GPIIA, MDF2, MSK12, VLA-4 Subunit beta, VLAB, VLA-BETA) (HRP)
Sign In for Pricing
View Details